definitive healthcare is the leading provider of data and intelligence on hospitals, physicians and other healthcare providers. their product suite provides the most comprehensive and highest quality data available anywhere on over 8,100 hospitals and idns, 7,300 ambulatory surgery centers, 11,000 imaging centers, 38,000 long-term care facilities, 1,200 acos and hies, 197,000 physician groups, 1.3 million physicians, and 750 canadian hospitals. the company’s data provides clients with the analytics and insight needed to effectively segment and research the healthcare provider market. definitive healthcare is backed by spectrum equity. for more information or to trial the service, visit www.definitivehc.com.
Company profile
Ticker
DH
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Microsoft • Oracle • Mobileye Global Inc - Ordinary Shares • Gen Digital • Activision Blizzard • Vmware • Adobe • Salesforce • BlackBerry • Dayforce ...
SEC CIK
Corporate docs
Subsidiaries
AIDH TopCo, LLC • AIDH Buyer, LLC • Definitive Healthcare Holdings, LLC • Definitive Healthcare, LLC • Analytical Wizards, Inc • Analytical Wizards Services Private Ltd • Monocl Holding Company, LLC • Monocl Company, LLC • Monocl AB • Healthcare Sales Enablement, LLC ...
DH stock data
Latest filings (excl ownership)
S-8
Registration of securities for employees
12 Jun 24
8-K
Departure of Directors or Certain Officers
24 May 24
DEFA14A
Additional proxy soliciting materials
7 May 24
10-Q
2024 Q1
Quarterly report
7 May 24
8-K
Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2024
7 May 24
ARS
2023 FY
Annual report to shareholders
9 Apr 24
DEFA14A
Additional proxy soliciting materials
9 Apr 24
DEF 14A
Definitive proxy
9 Apr 24
S-8
Registration of securities for employees
28 Feb 24
10-K
2023 FY
Annual report
28 Feb 24
Transcripts
DH
Earnings call transcript
2024 Q1
7 May 24
DH
Earnings call transcript
2023 Q4
28 Feb 24
DH
Earnings call transcript
2023 Q3
2 Nov 23
DH
Earnings call transcript
2023 Q2
14 Aug 23
DH
Earnings call transcript
2023 Q2
14 Aug 23
DH
Earnings call transcript
2023 Q1
4 May 23
DH
Earnings call transcript
2023 Q1
4 May 23
DH
Earnings call transcript
2022 Q4
23 Feb 23
DH
Earnings call transcript
2022 Q3
3 Nov 22
DH
Earnings call transcript
2022 Q2
7 Aug 22
Latest ownership filings
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 105.99 mm | 105.99 mm | 105.99 mm | 105.99 mm | 105.99 mm | 105.99 mm |
Cash burn (monthly) | 8.33 mm | 1.58 mm | 5.42 mm | 28.08 mm | (no burn) | (no burn) |
Cash used (since last report) | 21.65 mm | 4.11 mm | 14.08 mm | 72.99 mm | n/a | n/a |
Cash remaining | 84.35 mm | 101.89 mm | 91.91 mm | 33.01 mm | n/a | n/a |
Runway (months of cash) | 10.1 | 64.5 | 17.0 | 1.2 | n/a | n/a |
Institutional ownership, Q4 2023
27.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 19 |
Opened positions | 3 |
Closed positions | 119 |
Increased positions | 5 |
Reduced positions | 8 |
13F shares | Current |
---|---|
Total value | 80.38 bn |
Total shares | 32.59 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
SEA VII Management | 24.48 mm | $0.00 |
Conestoga Capital Advisors | 5.52 mm | $54.88 bn |
Riverbridge Partners | 1.74 mm | $17.29 bn |
Raymond James & Associates | 596.55 k | $5.93 bn |
Mirae Asset Global Investments | 90.24 k | $896.97 mm |
Baker Tilly Financial | 59.96 k | $595.96 mm |
Raymond James Trust N.a. | 28.69 k | $285.22 mm |
Trust Point | 20.78 k | $206.56 mm |
SG Americas Securities | 18.80 k | $187.00 k |
Arizona State Retirement System | 14.25 k | $141.68 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 May 24 | Winters Kathleen A | Class A Common Stock | Grant | Acquire A | No | No | 0 | 26,759 | 0.00 | 63,881 |
22 May 24 | Samuel A Hamood | Class A Common Stock | Grant | Acquire A | No | No | 0 | 26,759 | 0.00 | 58,840 |
22 May 24 | Sastry Chilukuri | Class A Common Stock | Grant | Acquire A | No | No | 0 | 26,759 | 0.00 | 70,883 |
22 May 24 | Stephenson Scott G | Class A Common Stock | Grant | Acquire A | No | No | 0 | 26,759 | 0.00 | 68,213 |
22 May 24 | Jill Larsen | Class A Common Stock | Grant | Acquire A | No | No | 0 | 26,759 | 0.00 | 58,840 |
News
Definitive Healthcare Appoints Kevin Coop As CEO, Effective June 24, 2024
28 May 24
Deutsche Bank Maintains Hold on Definitive Healthcare, Lowers Price Target to $7
9 May 24
Barclays Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $7
9 May 24
Buy Definitive Healthcare Stock On Weakness, Analyst Says As Revised Outlook Appears Achievable
8 May 24
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
8 May 24
Press releases
Definitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year Award
11 Jun 24
Definitive Healthcare Publishes 2023 Sustainability Report
3 Jun 24
Definitive Healthcare Announces Timing of Its First Quarter 2024 Financial Results Conference Call and Webcast
23 Apr 24
VML and Definitive Healthcare announce partnership to transform key opinion leader management
22 Mar 24